NASDAQ: RYOJRyojbaba Co Ltd Stock
$2.89-0.01 (-0.34%)
Updated Aug 15, 2025
RYOJ Price
$2.89
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$2.51
52 Week High
$3.75
P/E
22.23x
P/B
N/A
P/S
N/A
PEG
0.49x
Dividend Yield
N/A
Revenue
$11.58M
Earnings
$1.33M
Gross Margin
38.5%
Operating Margin
17.45%
Profit Margin
11.5%
Debt to Equity
5.37
Operating Cash Flow
$802k
Beta
N/A
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RYOJ Overview
rYojbaba Co., Ltd. provides health and consulting services for corporations in Japan. The Consulting Services segment offers labor and corporate consulting services to labor unions, companies to support the practice of whistleblowing and stress checks, and companies and labor unions to resolve disputes. The Health Service segment provides health services through osteopathic clinics and beauty salons to alleviate physical ailments primarily created by work related stress. rYojbaba Co., Ltd. was formerly known as Sakai Seikotsuin Co., Ltd. and changed its name to rYojbaba Co., Ltd. in October 2021. The company was founded in 2015 and is based in Fukuoka, Japan.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RYOJ's potential to beat the market
- RYOJ doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Consulting Service
Industry Rating
C
RYOJ
RankedUnranked of 16
RankedUnranked of 16
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $4.46 | B | |
| $9.58 | B | |
| $133.17 | C |
Be the first to know about important RYOJ news, forecast changes, insider trades & much more!
RYOJ News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RYOJ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RYOJ ($2.89) is trading below its intrinsic value of $2.90, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RYOJ is good value based on its earnings relative to its share price (22.23x), compared to the US market average (35.99x)
P/E vs Market Valuation
RYOJ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more RYOJ due diligence checks available for Premium users.
Valuation
RYOJ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
22.23x
Industry
37.84x
Market
35.99x
RYOJ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RYOJ is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
RYOJ price to earnings growth (PEG)
For valuing profitable companies with growth potential
RYOJ is good value based... subscribe to Premium to read more.
PEG Value Valuation
RYOJ's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
RYOJ's Earnings (EBIT) of $2.02M... subscribe to Premium to read more.
Interest Coverage Financials
RYOJ's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$16.1M
Liabilities
$13.5M
Debt to equity
5.37
RYOJ's short-term assets ($6.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RYOJ's long-term liabilities ($8.97M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RYOJ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
RYOJ's operating cash flow ($802.39k)... subscribe to Premium to read more.
Debt Coverage Financials
RYOJ vs Consulting Service Stocks
Ryojbaba Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.